Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...

Individual prediction uncertainty is a key aspect of clinical prediction model performance; however, standard performance metrics do not capture it. Consequently, a model might offer sufficient ...

Medicare Advantage (MA) insurers use provider networks, which may restrict access to mental health care. This study examines changes in mental health visits and specialties used before and after ...

Patient-centric evidence, such as PROs and RWE, offers insights into patients' needs, enhancing drug development beyond traditional endpoints. Challenges include increased complexity and regulatory ...

Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy December ...

A meta-analysis of 80,737 cases identifies five new variants and 22 risk genes, highlighting three potential drug targets for ...

Patients with polycythemia vera (PV), a rare cancer characterized by overabundant red blood cells, have endured years of middling progress in their therapeutic options. | Patients with polycythemia ...

The Adult Psychiatric Morbidity Survey provides the official statistics on trends over time in autism, psychotic disorder, bipolar disorder, drug and alcohol dependence ...

Background Many individuals initiating tuberculosis (TB) treatment do not successfully complete the regimen. Understanding variation in treatment outcomes could reveal opportunities to improve the ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...

Most Medicare beneficiaries reported manageable treatment burdens from health care. Among Medicare beneficiaries with heavier chronic condition burdens, 1 in 4 Medicare Advantage enrollees faced high ...

Rezolute (RZLT) is poised for growth with key Phase 3 trial results ahead. Ersodetug targets both congenital and ...